BDBM725038 (R)-5-(tert-butyl)-N-(2-(2- (cyclopropanecarboxamido) pyridin-4-yl)-1-fluoro- 6,7,8,9-tetrahydro-5H- benzo[7]annulen-5-yl)-1,2,4- oxadiazole-3-carboxamide::US12240838, Compound 40

SMILES CC(C)(C)c1nc(C(=O)N[C@@H]2CCCCc3c2ccc(-c2ccnc(NC(=O)C4CC4)c2)c3F)no1

InChI Key InChIKey=VZDJVAAQTAAICV-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 725038   

TargetTyrosine-protein kinase BTK(Human)
Biogen Ma

US Patent
LigandPNGBDBM725038((R)-5-(tert-butyl)-N-(2-(2- (cyclopropanecarboxami...)
Affinity DataIC50: 1nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/6/2025
Entry Details
US Patent